论文部分内容阅读
对成人急性淋巴细胞白血病(ALL)的治疗是有争议的。60～80%的病人能达到完全缓解,但大多数终究要复发。缓解后化疗和同种或自身骨髓移植被用于防止复发,这两种方法的结果有重叠,有报道5年无白血病生存率为20%～60%。直接比较化疗和移植的效果是不满意的。过去的文章只报道一种或另一种方法的结果,且病人的类型也不同;移植组通常并不包括第一次缓解时缓解期太短而不适宜做移植的病
The treatment of adult acute lymphoblastic leukemia (ALL) is controversial. 60-80% of patients can achieve complete remission, but most of them eventually have to relapse. Chemotherapy and homologous or autologous bone marrow transplantation were used to prevent recurrence after remission. The results of these two methods overlapped. There was a reported 5-year survival rate of 20% to 60% for leukemia. Direct comparison of the effects of chemotherapy and transplantation is not satisfactory. In the past articles only reported the results of one or another method, and the patient’s type is also different; transplantation group usually does not include the first remission of the remission period is too short and not suitable for transplantation